Faculty and Staff

Professor, Departments of Biostatistics and Epidemiology, Boston University, School of Public Health

Dr. Fish has a long history of research in the areas of clinical toxicology and emergency medicine. She has most recently focused on research ethics in general, and application of the federal regulations for waiver of informed consent in certain emergency research circumstances. Issues relating to the design of clinical research and ethical implications of study designs are Dr. Fish’s areas of expertise.

She is the former director of the IRB for the Boston University Medical Campus and Boston Medical Center. She is currently a member of faculty of Fordham University’s HIV and Drug Abuse Prevention Research Ethics Training Institute.

Amy has over 17 years of experience providing clinical and regulatory affairs consulting to industry sponsors and academic institutions.  She specializes in regulatory strategy, product submissions and clinical study compliance.  She has worked extensively with medical device, in vitro diagnostic and pharmaceutical companies on FDA submissions and management of clinical studies.  Amy previously served as Vice President at Health Policy Associates Inc. and for the past two years has been an independent consultant.  Amy received her JD from Tulane University in 1991 and her MPH (with concentrations in Health Law and Health Services) from Boston University in 1994.

Tom Travison is Associate Professor of Medicine at Harvard Medical School, and Senior Scientist at the Marcus Institute for Aging Research, Hebrew SeniorLife, where he directs the Biostatistics and Data Science center and is co-director of the center for Interventional Studies. His collaborative work is focused on multimodal interventions for the prevention and amelioration of syndromes of aging. His laboratory also focuses on the development and dissemination of software tools for reproducible biomedical research.

Victoria Lattanzi is a graduate of Brown University with a BS in Biology and Boston University School of Medicine with an MS in Clinical Investigation. Victoria started her research career as a bench scientist working in various academic laboratories throughout Boston, MA and developed extensive in vitro and in vivo pre-clinical technical skills. She is published in the fields of hematology/oncology, regenerative biology and biochemistry.

In 2010 she made the transition to clinical research and has gained extensive clinical trial experience in an academic setting. As a Clinical Research Associate within the Boston University Amyloidosis Center, Victoria was responsible for the management of the Center’s clinical trials. Her responsibilities included coordination of study start-up activities, regulatory submissions, subject recruitment, coordination of study visits and data collection. In 2016, she moved from site level clinical research to the industry side as she joined Halloran Consulting Group as a consultant within the biotechnology and pharmaceutical practice area. In this role, she worked as part of project teams to provide clinical operational support to clients in the life sciences industry. Currently, Victoria is working as a Clinical Trial Manager at BlueRock Therapeutics, an engineered cell therapy company headquartered in Cambridge, MA.

Carrie Melvin began teaching the Introduction to Clinical Trial Management course here at BU in the Spring of 2023. She has extensive experience  in the Pharmaceutical and Biotechnology space, having worked in the drug development industry for over 24 years. She began her career at Pfizer, Inc in Groton, CT as a Clinical Research Manager and continued to advance her career during her 8.5 years at the company. After her time with Pfizer, she moved to the Boston area with her husband of 27+ years and her two amazing children.